Positive Clinical Effects in the Early Stages of Alzheimer’s Disease: A Focus on Disease-Modifying Therapies
Alzheimer’s disease research is entering a groundbreaking phase with the development of disease-modifying therapies that target early-stage pathology. At the Nordic Evening, Kristian Steen Frederiksen from the Danish Dementia Research Centre highlighted the pivotal role of these therapies, focusing on amyloid and tau proteins, and the importance of early diagnosis in optimizing treatment outcomes.
